Use of FHCRC Cell Processing Facility Sample Clauses

Use of FHCRC Cell Processing Facility. (a) For a period of [***] commencing on the Effective Date or as otherwise agreed by the parties, at Juno’s request, FHCRC agrees to produce at its Cell Processing Facility in Seattle, Washington any human cellular and tissue based Study Product (“HCT Study Product”) for any Collaboration Projects; provided, that FHCRC will only be required to manufacture HCT Study Products for which it determines in its reasonable discretion that it has the capacity and expertise to do so. (b) The terms for production of any HCT Study Product produced by FHCRC including pricing, manufacturing and release specifications, and quality control and quality assurance testing will be described in the applicable Project Agreement. (c) FHCRC agrees to maintain reasonable documentation concerning the production services, including documentation of all production and quality control testing, standard operating procedures, batch records, logs and such other matters as may be required by law or by the specifications described in the applicable Project Agreement (“Production Data”). All Production Data will be maintained by FHCRC in a secure location and access will be limited to authorized FHCRC and Juno personnel (including consultants and advisors); provided, at Juno’s request, and subject to reasonable confidentiality restrictions, copies of such Production Data will be made available to potential manufacturers of Licensed Products. Based on its prior experience with similar products, FHCRC will develop a [***] schedule for production, testing and delivery of the each HCT Study Product. FHCRC agrees to [***] to produce, test and deliver any HCT Study Product in accordance with the schedule described in the Project Agreement [***]. (d) Unless otherwise agreed, and subject to any licenses between FHCRC and Juno, Production Data will be owned by and considered Confidential Information of [***]. Any disclosure to a third party must be subject to confidentiality restrictions at set forth in Article 8. (e) Notwithstanding Section 12 and unless otherwise expressly agreed in writing by the parties (including in any applicable Project Agreement), FHCRC hereby grants to Juno an exclusive, perpetual, royalty free license, with the right to sublicense through multiple tiers, to any Project Intellectual Property (as defined in Section 12.1) owned by FHCRC that constitutes an improvement to any process used to manufacture HCT Products, in each case, for the development and/or commercialization o...